These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 34999269)
1. Exploring Televend, an innovative combination of cryptomarket and messaging app technologies for trading prohibited drugs. Barratt MJ; Lamy FR; Engel L; Davies E; Puljevic C; Ferris JA; Winstock AR Drug Alcohol Depend; 2022 Feb; 231():109243. PubMed ID: 34999269 [TBL] [Abstract][Full Text] [Related]
2. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time. Tzanetakis M Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105 [TBL] [Abstract][Full Text] [Related]
3. The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study. Coney L; Peacock A; Malm A; Munksgaard R; Aldridge J; Ferris JA; Maier LJ; Winstock AR; Barratt MJ Int J Drug Policy; 2024 Jan; 123():104258. PubMed ID: 38056221 [TBL] [Abstract][Full Text] [Related]
4. Illicit drug prices and quantity discounts: A comparison between a cryptomarket, social media, and police data. Moeller K; Munksgaard R; Demant J Int J Drug Policy; 2021 May; 91():102969. PubMed ID: 33041184 [TBL] [Abstract][Full Text] [Related]
5. Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange. Sawicka M; Rafanell I; Bancroft A Int J Drug Policy; 2022 Feb; 100():103514. PubMed ID: 34768125 [TBL] [Abstract][Full Text] [Related]
6. Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data. Rhumorbarbe D; Staehli L; Broséus J; Rossy Q; Esseiva P Forensic Sci Int; 2016 Oct; 267():173-182. PubMed ID: 27611957 [TBL] [Abstract][Full Text] [Related]
7. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network. Norbutas L Int J Drug Policy; 2018 Jun; 56():92-100. PubMed ID: 29621742 [TBL] [Abstract][Full Text] [Related]
8. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement. Aldridge J; Askew R Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207 [TBL] [Abstract][Full Text] [Related]
9. Safer scoring? Cryptomarkets, social supply and drug market violence. Barratt MJ; Ferris JA; Winstock AR Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015 [TBL] [Abstract][Full Text] [Related]
10. An island apart? Risks and prices in the Australian cryptomarket drug trade. Cunliffe J; Martin J; Décary-Hétu D; Aldridge J Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855 [TBL] [Abstract][Full Text] [Related]
11. 'Nice people doing shady things': Drugs and the morality of exchange in the darknet cryptomarkets. Masson K; Bancroft A Int J Drug Policy; 2018 Aug; 58():78-84. PubMed ID: 29870962 [TBL] [Abstract][Full Text] [Related]
12. Social influence in the darknet market: The impact of product descriptions on cocaine sales. Andrei F; Veltri GA Int J Drug Policy; 2024 Feb; 124():104328. PubMed ID: 38245917 [TBL] [Abstract][Full Text] [Related]
13. 'Choice' of social media platform or encrypted messaging app to buy and sell illegal drugs. van der Sanden R; Wilkins C; Rychert M; Barratt MJ Int J Drug Policy; 2022 Oct; 108():103819. PubMed ID: 35961237 [TBL] [Abstract][Full Text] [Related]
14. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets. Aldridge J; Décary-Hétu D Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863 [TBL] [Abstract][Full Text] [Related]
15. Reputation transferability across contexts: Maintaining cooperation among anonymous cryptomarket actors when moving between markets. Norbutas L; Ruiter S; Corten R Int J Drug Policy; 2020 Feb; 76():102635. PubMed ID: 31972474 [TBL] [Abstract][Full Text] [Related]
16. Who sells what? Country specific differences in substance availability on the Agora cryptomarket. Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115 [TBL] [Abstract][Full Text] [Related]
17. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis. Cunliffe J; Décary-Hêtu D; Pollak TA Int J Drug Policy; 2019 Nov; 73():263-272. PubMed ID: 30772109 [TBL] [Abstract][Full Text] [Related]
18. Using the Event Analysis of Systemic Teamwork (EAST) broken-links approach to understand vulnerabilities to disruption in a darknet market. Lane BR; Salmon PM; Cherney A; Lacey D; Stanton NA Ergonomics; 2019 Sep; 62(9):1134-1149. PubMed ID: 31117925 [TBL] [Abstract][Full Text] [Related]
19. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets. Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810 [TBL] [Abstract][Full Text] [Related]
20. Sellers' risk perceptions in public and private social media drug markets. Bakken SA; Demant JJ Int J Drug Policy; 2019 Nov; 73():255-262. PubMed ID: 31053409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]